International Journal of Molecular Sciences (Aug 2023)

ERAP1 and ERAP2 Haplotypes Influence Suboptimal HLA-B*27:05-Restricted Anti-Viral CD8+ T Cell Responses Cross-Reactive to Self-Epitopes

  • Valentina Tedeschi,
  • Giorgia Paldino,
  • Josephine Alba,
  • Emanuele Molteni,
  • Fabiana Paladini,
  • Rossana Scrivo,
  • Mattia Congia,
  • Alberto Cauli,
  • Rosalba Caccavale,
  • Marino Paroli,
  • Manuela Di Franco,
  • Loretta Tuosto,
  • Rosa Sorrentino,
  • Marco D’Abramo,
  • Maria Teresa Fiorillo

DOI
https://doi.org/10.3390/ijms241713335
Journal volume & issue
Vol. 24, no. 17
p. 13335

Abstract

Read online

The human leukocyte antigen (HLA)-B*27 family of alleles is strongly associated with ankylosing spondylitis (AS), a chronic inflammatory disorder affecting the axial and peripheral joints, yet some HLA-B*27 variants not associated with AS have been shown. Since no major differences in the ligandome of associated compared to not-associated alleles have emerged, a plausible hypothesis is that the quantity rather than the quality of the presented epitopes makes the difference. In addition, the Endoplasmic Reticulum AminoPeptidases (ERAPs) 1 and 2, playing a crucial role in shaping the HLA class I epitopes, act as strong AS susceptibility factors, suggesting that an altered peptidome might be responsible for the activation of pathogenic CD8+ T cells. In this context, we have previously singled out a B*27:05-restricted CD8+ T cell response against pEBNA3A (RPPIFIRRL), an EBV peptide lacking the B*27 classic binding motif. Here, we show that a specific ERAP1/2 haplotype negatively correlates with such response in B*27:05 subjects. Moreover, we prove that the B*27:05 allele successfully presents peptides with the same suboptimal N-terminal RP motif, including the self-peptide, pDYNEIN (RPPIFGDFL). Overall, this study underscores the cooperation between the HLA-B*27 and ERAP1/2 allelic variants in defining CD8+ T cell reactivity to suboptimal viral and self-B*27 peptides and prompts further investigation of the B*27:05 peptidome composition.

Keywords